Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00212654

Enrollment

165

Registered

2005-09-21

Start date

2001-06-30

Completion date

Unknown

Last updated

2012-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Supraventricular Tachyarrythmia

Keywords

ONO-1101, Landiolol Hydrochloride, Postoperative, supraventricular tachyarrhythmia

Brief summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in postoperative supraventricular tachyarrhythmias.

Interventions

DRUGONO-1101

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

21 Years to 84 Years

Healthy volunteers

Inclusion criteria

1. 20 years or older 2. Postoperative supraventricular tachyarrhythmias 3. Within 7 days postoperatively 4. Other inclusion criteria as specified in the protocol

Exclusion criteria

1. Acute myocardial infarction (within 1 month after onset) 2. Severe heart failure \[New York Heart Association (NYHA) functional class III or higher\] 3. Atrioventricular block (grade II or higher), or sick sinus syndrome 4. Other

Design outcomes

Primary

Measure	Time frame
Percentage of patients who met the heart rate reduction criteria (20% reduction from the baseline heart rate and a heart rate of <100 beats/min)	—

Secondary

Measure	Time frame
Heart rate, blood pressure, rate-pressure-product and ECG	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026